Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001171843-20-002216
Filing Date
2020-04-01
Accepted
2020-04-01 08:00:23
Documents
4
Period of Report
2020-04-01

Document Format Files

Seq Description Document Type Size
1 FORM 6-K f6k_040120.htm 6-K 176071
2 GRAPHIC logo.jpg GRAPHIC 6425
3 GRAPHIC pcard_1.jpg GRAPHIC 1703013
4 GRAPHIC pcard_2.jpg GRAPHIC 1064106
  Complete submission text file 0001171843-20-002216.txt   3993725
Mailing Address 21 HA'ARBA'A STREET TEL AVIV L3 64739
Business Address 21 HA'ARBA'A STREET TEL AVIV L3 64739 972-3-541-3131
RedHill Biopharma Ltd. (Filer) CIK: 0001553846 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3
Type: 6-K | Act: 34 | File No.: 001-35773 | Film No.: 20763756
SIC: 2834 Pharmaceutical Preparations